These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 24013388)

  • 1. Mycoplasma fermentans inhibits the activity of cellular DNA topoisomerase I by activation of PARP1 and alters the efficacy of its anti-cancer inhibitor.
    Afriat R; Horowitz S; Priel E
    PLoS One; 2013; 8(8):e72377. PubMed ID: 24013388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Poly(ADP-ribosyl)ation as a DNA damage-induced post-translational modification regulating poly(ADP-ribose) polymerase-1-topoisomerase I interaction.
    Yung TM; Sato S; Satoh MS
    J Biol Chem; 2004 Sep; 279(38):39686-96. PubMed ID: 15247263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of DNA topoisomerase activity in two strains of Mycoplasma fermentans and in Mycoplasma pirum.
    Horowitz S; Maor R; Priel E
    J Bacteriol; 1997 Nov; 179(21):6626-32. PubMed ID: 9352909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preferential potentiation of topoisomerase I poison cytotoxicity by PARP inhibition in S phase.
    Znojek P; Willmore E; Curtin NJ
    Br J Cancer; 2014 Sep; 111(7):1319-26. PubMed ID: 25003660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced killing of cancer cells by poly(ADP-ribose) polymerase inhibitors and topoisomerase I inhibitors reflects poisoning of both enzymes.
    Patel AG; Flatten KS; Schneider PA; Dai NT; McDonald JS; Poirier GG; Kaufmann SH
    J Biol Chem; 2012 Feb; 287(6):4198-210. PubMed ID: 22158865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Poly(ADP-ribose) polymerase-1 could facilitate the religation of topoisomerase I-linked DNA inhibited by camptothecin.
    Park SY; Cheng YC
    Cancer Res; 2005 May; 65(9):3894-902. PubMed ID: 15867389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Poly(ADP-ribose) polymers regulate DNA topoisomerase I (Top1) nuclear dynamics and camptothecin sensitivity in living cells.
    Das SK; Rehman I; Ghosh A; Sengupta S; Majumdar P; Jana B; Das BB
    Nucleic Acids Res; 2016 Sep; 44(17):8363-75. PubMed ID: 27466387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modification of topoisomerases in mammospheres derived from breast cancer cell line: clinical implications for combined treatments with tyrosine kinase inhibitors.
    Peleg R; Romzova M; Kogan-Zviagin I; Apte RN; Priel E
    BMC Cancer; 2014 Dec; 14():910. PubMed ID: 25472619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations of human DNA topoisomerase I at poly(ADP-ribose) binding sites: modulation of camptothecin activity by ADP-ribose polymers.
    Tesauro C; Graziani G; Arnò B; Zuccaro L; Muzi A; D'Annessa I; Santori E; Tentori L; Leonetti C; Fiorani P; Desideri A
    J Exp Clin Cancer Res; 2014 Sep; 33(1):71. PubMed ID: 25227992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ATP modulates poly(ADP-ribose) polymerase-1-facilitated topoisomerase I-linked DNA religation in the presence of camptothecin.
    Park SY; Leung CH; Cheng YC
    Mol Pharmacol; 2008 Jun; 73(6):1829-37. PubMed ID: 18349103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Poly(ADP-ribose) polymerase signaling of topoisomerase 1-dependent DNA damage in carcinoma cells.
    D'Onofrio G; Tramontano F; Dorio AS; Muzi A; Maselli V; Fulgione D; Graziani G; Malanga M; Quesada P
    Biochem Pharmacol; 2011 Jan; 81(2):194-202. PubMed ID: 20875401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The novel poly(ADP-Ribose) polymerase inhibitor, AG14361, sensitizes cells to topoisomerase I poisons by increasing the persistence of DNA strand breaks.
    Smith LM; Willmore E; Austin CA; Curtin NJ
    Clin Cancer Res; 2005 Dec; 11(23):8449-57. PubMed ID: 16322308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular interactions between poly(ADP-ribose) polymerase (PARP I) and topoisomerase I (Topo I): identification of topology of binding.
    Bauer PI; Chen HJ; Kenesi E; Kenessey I; Buki KG; Kirsten E; Hakam A; Hwang JI; Kun E
    FEBS Lett; 2001 Oct; 506(3):239-42. PubMed ID: 11602253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delocalization of nucleolar poly(ADP-ribose) polymerase-1 to the nucleoplasm and its novel link to cellular sensitivity to DNA damage.
    Rancourt A; Satoh MS
    DNA Repair (Amst); 2009 Mar; 8(3):286-97. PubMed ID: 19144573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of topoisomerase I by poly [ADP-ribose] polymerase.
    Bauer PI; Buki KG; Comstock JA; Kun E
    Int J Mol Med; 2000 May; 5(5):533-40. PubMed ID: 10762658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CK2-mediated hyperphosphorylation of topoisomerase I targets serine 506, enhances topoisomerase I-DNA binding, and increases cellular camptothecin sensitivity.
    Bandyopadhyay K; Li P; Gjerset RA
    PLoS One; 2012; 7(11):e50427. PubMed ID: 23185622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Real-time imaging of drug-induced trapping of cellular topoisomerases and poly(ADP-ribose) polymerase 1 at the single-molecule level.
    Sun Y; Chen J; Pommier Y
    Nucleic Acids Res; 2023 Oct; 51(18):e97. PubMed ID: 37670571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein expression of DNA damage repair proteins dictates response to topoisomerase and PARP inhibitors in triple-negative breast cancer.
    Boerner JL; Nechiporchik N; Mueller KL; Polin L; Heilbrun L; Boerner SA; Zoratti GL; Stark K; LoRusso PM; Burger A
    PLoS One; 2015; 10(3):e0119614. PubMed ID: 25774912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Poly(ADP-ribosylation) of a DNA topoisomerase.
    Ferro AM; Higgins NP; Olivera BM
    J Biol Chem; 1983 May; 258(10):6000-3. PubMed ID: 6304023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of poly(ADP-ribose) polymerase cleavage in response to treatment with topoisomerase I inhibitors: a potential surrogate end point to assess treatment effectiveness.
    Whitacre CM; Zborowska E; Willson JK; Berger NA
    Clin Cancer Res; 1999 Mar; 5(3):665-72. PubMed ID: 10100720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.